ENTITY
Antengene

Antengene (6996 HK)

46
Analysis
Health Care • China
Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.
more
bullish•Ant Group
•01 Nov 2020 11:23

ECM Weekly (1 November 2020) - Ant Group, Sunac Services, New Oriental HK, Bio-Thera

This week, much of the focus is on Ant whereas HK had a disappoint start with the poor debut of KWG Living and Shimao Services. On the other hand,...

Share
bullish•Ant Group
•25 Oct 2020 11:14

ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...

Share
bullish•Antengene
•21 Oct 2020 10:37

Antengene (å¾·ēŖåŒ»čÆ) Pre-IPO: Proven R&D Track Record by Founder Matters

Antengene, a China-based biotech company with a focus on in-licensed innovative oncology drugs. The company was founded by Dr Jay Mei, an ex...

Logo
530 Views
Share
x